The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Risk stratification based on a prognostic factor index among patients with HR+, HER2- MBC.
 
Gregory A. Vidal
Consulting or Advisory Role - Lilly; Pfizer
Speakers' Bureau - AstraZeneca; Pfizer
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb; EMD Serono; Genentech/Roche; Lilly; Pfizer; Puma Biotechnology; Tesaro
 
Gebra Cuyun Carter
Employment - Lilly
 
Adrienne Gilligan
Employment - IBM; Vector Oncology
 
Kim Saverno
Employment - Lilly
 
Yajun Emily Zhu
Employment - Lilly
 
Gregory L Price
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Angelo DeLuca
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Emily Nash Nash Smyth
Employment - Lilly
Stock and Other Ownership Interests - Lilly
Research Funding - Lilly
 
Andrew G. Koustenis
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Yujing Huang
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Lee S. Schwartzberg
Stock and Other Ownership Interests - Vector Oncology
Honoraria - Amgen; E.R. Squibb Sons, LLC; Genentech; Helsinn Healthcare; NanoString Technologies; Napo Pharmaceuticals; Novartis; Pfizer; Pfizer; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Caris Life Sciences; E.R. Squibb Sons, LLC; Genentech; Genomic Health; Helsinn Therapeutics; Lilly; Novartis; Pfizer; Roche; Spectrum Pharmaceuticals; Tesaro; Vector Oncology
Research Funding - Amgen (Inst); Bayer Health (Inst); E.R. Squibb Sons, LLC (Inst); E.R. Squibb Sons, LLC (Inst); Genentech (Inst); GlaxoSmithKline (Inst); MedImmune (Inst); Medivation (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst); Spectrum Pharmaceuticals (Inst); Tesaro (Inst)